Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells.
CONCLUSION: The findings in this study provide evidence that DHODH inhibitors perturb the proliferation of non-cancerous cells via a distinct mechanism compared to cancerous cells. These results may lead to strategies for overcoming the impact on non-cancerous cells during treatment with DHODH inhibitors, leading to better therapeutic window in patients.
PMID: 32525770 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Kadir MFA, Othman S, Nellore K Tags: Curr Pharm Biotechnol Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Biotechnology | Cancer | Cancer & Oncology | Leukemia | Lymphoma | Mitochondria | Sodium | Study